Posted on April 23, 2008 by ecreese
Attendees awoke to the news this morning about GlaxoSmithKline’s announcement that it will pay millions — $720 million to be exact — for Sirtris Pharmaceuticals. This is the stuff biotech CEOs dream about. And it was the buzz at many breakfast tables at this morning’s workshop, “Antibiotics: Bad Bugs – Few Drugs.”
The BNVC meeting, of [...]
Filed under: national venture conference | Tagged: BIO, biotechnology, Biotechnology Industry Organization, national venture conference, venture funding | No Comments »
Posted on April 22, 2008 by ecreese
While the economy may not be as robust as it has in recent years, there certainly was no sign of that at today’s Opening Luncheon. Jim Greenwood, our President & CEO welcomed attendees to the inaugural BIO National Venture Conference and cited these impressive stats:
140 top-level (VP and higher) venture capitalists – including 4 international investors – [...]
Filed under: national venture conference | Tagged: BIO, biotechnology, Biotechnology Industry Organization, national venture conference, nvc, venture funding | No Comments »
Posted on April 22, 2008 by ecreese
The marathon may be over, but that doesn’t mean there isn’t plenty more activity going on here in Boston. We’re here in Cambridge, one of biotechnology’s “hot-spots” for the inaugural BIO National Venture Conference meeting up with some of the newest early stage and seed stage companies seeking venture funding. Stay tuned for more as the [...]
Filed under: national venture conference | Tagged: BIO, biotechnology, Biotechnology Industry Organization, bnvc, national venture conference, venture funding | No Comments »
susanatbio
TKtraveler
nicoleatbio
ecreese
sourav123
Jennifer Miller
Darren Fast
christineross
arubenstein
patentbaristas
sdmimi
mikesgene
